期刊文献+

芪苈强心胶囊治疗慢性心力衰竭的疗效观察 被引量:6

Effects of Qiliqiangxin Capsules in Patients with Heart Failure
下载PDF
导出
摘要 目的观察芪苈强心胶囊治疗慢性心力衰竭患者的临床疗效。方法将120例患者随机分为两组,对照组常规应用血管转换酶抑制剂、β受体阻滞剂、利尿剂等,治疗组在常规治疗基础上加用芪苈强心胶囊治疗,疗程8周。观察Lee氏心力衰竭积分、左室舒张末内径、左室射血分数(LVEF)、血浆NT-proBNP水平及肝肾功、电解质。结果两组治疗后Lee氏心力衰竭积分、左室舒张末内径、左室射血分数(LVEF)、血浆NT-proBNP水平均明显改善(P<0.01),但治疗组患者治疗后的改善更明显,优于对照组(P<0.05)。结论芪苈强心胶囊联合西药常规治疗慢性心力衰竭患者,可以更有效地改善患者心功能,缓解临床症状,且安全性较好。 Objective To investigate the effect of Qiliqiangxin capsules in patients with chronic heart failure. Method 120 patients were randomly divided into two groups, control group routine application of vascular converting enzyme inhibitors, beta-blockers, diuretics, such as the treatment group on the basis of conventional treatment combined with Qiliqiangxin capsules, course of 8 weeks. Observation of Lee's integral heart failure, left ventricular end-diastolic diameter, left ventricular ejection fraction (LVEF), plasma NT-proBNP levels and liver and kidney function, electrolyte. Results Lee's heart failure in the two groups after treatment of integral, left ventricular end-diastolic diameter and left ventricular ejection fraction (LVEF), plasma NT-proBNP levels were significantly improved (P〈0.01), but the treatment group improved more obviously after treatment, is better than that of control group (P〈0.05). Conclusions Qiliqiangxin capsules combined conventional western medicine treatment of chronic heart failure patients, can more effectively improves cardiac function in patients, relieve the clinical symptoms, and good security.
作者 孙盘丽
出处 《中国医药指南》 2014年第14期6-7,共2页 Guide of China Medicine
关键词 芪苈强心胶囊 心力衰竭 Qiliqiangxin capsules Chronic heart failure
  • 相关文献

参考文献4

二级参考文献49

  • 1吴以岭.络病与血管病变的相关性研究及治疗[J].中医杂志,2006,47(3):163-165. 被引量:135
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 3刘建勋,马晓斌,王杨慧.芪苈强心胶囊对实验性心力衰竭犬心脏功能的影响[J].疑难病杂志,2007,6(3):141-143. 被引量:40
  • 4魏聪,贾振华,吴以岭,刘建勋.芪苈强心胶囊对兔实验性慢性心力衰竭心室重构的保护作用[J].疑难病杂志,2007,6(3):144-147. 被引量:54
  • 5陈可冀.心脑血管疾病研究[M].上海:上海科学技术出版社,1988.311—318.
  • 6Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 7Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 8Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 9Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 10Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.

共引文献3700

同被引文献130

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部